SETD2 and colorectal cancer: In colorectal cancer, further analysis revealed that TMB in non-MSI SETD2 mutant tumors (4.9, 2.8–132.2) was significantly higher than TMB in non-MSI SETD2 nonmutant tumors (2.5, 2.0–3.3; P < 0.0001).